If they can prove increasing revenue in this new space and likewise avoid a CR (i think that is touch and go) then I will be looking to grab a whole lot more. In the back of my mind I am also slightly worried that the DCB might come back to bite them, but it's still worth the risk in my mind.
I think today's little wake up from the slumber is more than just a traders play.
Some will be looking to sell out and grab a tax loss on a small rise, but others like myself are ready to nab a deal.
- Forums
- ASX - By Stock
- IMS
- Ann: IMS Investor Presentation April 2018
Ann: IMS Investor Presentation April 2018, page-38
Featured News
Add IMS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online